SLGL Stock Summary and Trading Ideas (Sol-Gel Technologies Ltd. - | NASDAQ:SLGL)

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Sol-Gel Technologies Ltd. - trades on the NASDAQ stock market under the symbol SLGL.

As of December 31, 2025, SLGL stock price declined to $42.14 with 37,245 million shares trading.

SLGL has a beta of 1.10, meaning it tends to be more sensitive to market movements. SLGL has a correlation of 0.02 to the broad based SPY ETF.

SLGL has a market cap of $117.39 million. This is considered a Micro Cap stock.

Last quarter Sol-Gel Technologies Ltd. - reported $400,000 in Revenue and -$2.13 earnings per share. This beat revenue expectation by $100,000 and missed earnings estimates by -$.04.

In the last 3 years, SLGL traded as high as $57.10 and as low as $3.34.

SLGL has outperformed the market in the last year with a return of +276.3%, while the SPY ETF gained +17.2%. In the last 3 month period, SLGL beat the market returning +44.6%, while SPY returned +2.7%. However, in the most recent 2 weeks SLGL has underperformed the stock market by returning 0.0%, while SPY returned +0.7%.

SLGL support price is $39.22 and resistance is $45.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLGL shares will trade within this expected range on the day.